Daito Pharmaceutical Co 4577.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4577.T. It has been listed since 24 March 2010. In the fiscal year to 31 May 2026, it reported revenue of ¥50.65bn and net income of ¥3.16bn. At that date it held total assets of ¥73.29bn and shareholders' equity of ¥52.89bn.

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Yasunobu OhtsugaChairman of the Board, Chief Executive Officer, Representative Director, since 2007
• Mr. Hiroshi MatsumoriPresident, Chief Executive Officer, Representative Director, since 2023
• Mr. Kazushige HizumeManaging Executive Officer, Chief Director of Pharmaceuticals, Director, since 2016
• Mr. Hiroshi KubotaManaging Executive Officer, Chief Director of Reliability Assurance, Manager of Pharmaceutical Affairs Office
• Mr. Yutaka KuwashimaManaging Executive Officer, Chief Director of Drug Substance, Manager of Tokyo Office
• Mr. Toru IshidaExecutive Officer, Chief Director of Production, Director of Formulation Manufacturing, Manager of Environment and Safety Office, Director, since 2023
• Mr. Norio KishiExecutive Officer, Chief Director of Purchasing & Logistics, Director of International Business, Manager of Osaka Office, President and CEO of Subsidiary
• Mr. Masahiko MouriExecutive Officer, Deputy Chief Director of Production, Director of API Production, Manager of API Technical Office
• Mr. Yoshinori NakajimaExecutive, Deputy Chief Director of Main Production Unit, Director of Production Management
• Mr. Yoji NakamuraExecutive Officer, Deputy Chief Director of Quality and Regulatory Affairs, Director of Quality Assurance
• Mr. Eiichi TakataExecutive Officer, Chief Director of Research and Development
• Mr. Masuo NomuraDirector, since 2011

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.